Comparing the effect of chloroquine eye drops with olopatidine drops versus olopatidine eye drops alone in patients of allergic keratoconjunctivitis.
Not Applicable
- Conditions
- Health Condition 1: null- Allergic keratoconjunctivitisHealth Condition 2: H162- Keratoconjunctivitis
- Registration Number
- CTRI/2018/09/015679
- Lead Sponsor
- FDC Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients coming in the outpatient department with ocular itching, redness and watering and diagnosed as a case of seasonal allergic conjunctivitis on the basis of sign (hyperemia and papillaae) at slit lamp examination.
Exclusion Criteria
1. Uveitis, conjunctivitis (due to other cause) and other ocular pathology.
2. Bronchial asthma, eczema.
3. History of dry eye, blepharitis, using contact lens.
4. Receiving topical or systemic medication.
5. History of hypersensitivity to any constituents of the eye drops.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptom control <br/ ><br>Timepoint: follow up 1week, 4 week, 8 week and 12 week.
- Secondary Outcome Measures
Name Time Method 1. decrease in tear osmolarity <br/ ><br>2. decrease in Inflammtory markers MMP9 Alpha antitrypsin, Interleukin1, interleukin 8, interferon gamma levelTimepoint: before treatment and at last follow up